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Edited by Gianni CesareniAbstract Heterogeneous nuclear ribonucleoprotein K (hnRNP-
K) was identiﬁed as interacting cellular protein with the abun-
dant immediate early protein p30 from African swine fever virus
(ASFV) in a macrophage cDNA library screening. The interact-
ing regions of hnRNP-K with p30 were established within resi-
dues 35–197, which represent KH1 and KH2 domains
responsible for RNA binding. Colocalization of hnRNP-K and
p30 was observed mainly in the nucleus, but not in the cytoplasm
of infected cells and infection modiﬁed hnRNP-K subcellular dis-
tribution and decreased the incorporation of 5-ﬂuorouridine into
nascent RNA. Since similar eﬀects were observed in cells tran-
siently expressing p30, this interaction provides new insights into
p30 function and could represent a possible additional mecha-
nism by which ASFV downregulates host cell mRNA translation.
Structured summary:
MINT-6742660:
hnRNP-K (uniprotkb:P61978) physically interacts (MI:0218)
with p30 (uniprotkb:Q8V1E7) by pull down (MI:0096)
MINT-6742673, MINT-6742696, MINT-6742729:
hnRNP-K (uniprotkb:P61978) physically interacts (MI:0218)
with p30 (uniprotkb:Q8V1E7) by two hybrid (MI:0018)
MINT-6742711:
p30 (uniprotkb:Q8V1E7) and hnRNP-K (uniprotkb:P61978)
colocalize (MI:0403) by ﬂuorescence microscopy (MI:0416)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V.
Keywords: African swine fever virus; p30; Ribonucleoproteins;
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Open access under CC BY-NC-ND license.1. Introduction
African swine fever virus (ASFV), the only member of the
Asfarviridae family, is a large, cytoplasmic, double-stranded
DNA virus that is responsible of a haemorrhagic and fre-
quently fatal disease of swine [1]. The viral genome comprises
more than 150 open reading frames and expression is regulated
in a temporal fashion. So, viral genes are classiﬁed as early or
late depending on their requirement for viral DNA synthesis
[2]. Little is known about the regulatory functions of ASFV
proteins during infection and early virus proteins are impor-Abbreviations: ASFV, African swine fever virus; GST, glutathione S-
transferase; FU, 5-ﬂuorouridine; hpi, hours post infection
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doi:10.1016/j.febslet.2008.08.031tant candidates to play critical roles in the modiﬁcation of cel-
lular metabolism to take advantage of host cell functions.
ASFV open reading frame CP204L encodes a 30 kDa pro-
tein named p30 or p32 [3,4] which represents the most abun-
dantly expressed viral protein early in infection. p30 exhibits
a predominantly cytoplasmic location within infected cells
and results phosphorylated in serine residues at the N-terminal
[4] before its ﬁnal incorporation to the viral particle. p30 is also
one of the most antigenic ASFV proteins [5], eliciting virus
neutralizing antibodies in infected animals [6–8]. Previous
studies have demonstrated a role for p30 in ﬁrst stages of infec-
tion, since antibodies against p30 are able to inhibit virus inter-
nalization into the host cell [6]. Nevertheless, the regulatory
function of p30 upon infection remains largely unknown.
To explore the potential targets of p30 during infection, we
have used the yeast two-hybrid system to screen a porcine mac-
rophage (the natural viral host cell) cDNA library for cellular
proteins that may interact with p30. We have identiﬁed heter-
ogeneous nuclear ribonucleoprotein K (hnRNP-K) as the ﬁrst
cellular ligand of p30.
hnRNP-K is a multifunctional protein since it has been de-
scribed to interact with diverse molecules of cellular [9,10],
and viral origin [11–14], being involved in a variety of cellular
functions such as regulation of transcription and translation
[15], RNA splicing, mRNA stability and transport of pre-
mRNA out of nucleus to cytoplasm. It has been demonstrated
to interact with diﬀerent molecules involved in signal transduc-
tion such as Src, Fyn and Lyn [16]. Recently, a number of new
hnRNP-K partners have been identiﬁed by using a proteomic
approach [17] and new roles have been suggested for this pro-
tein. ASFV p30 was found to interact directly with host
hnRNP-K during ASFV infection and we have mapped the
interacting regions of both proteins. p30 modiﬁes hnRNP-K
subcellular distribution and could contribute to modulate
hnRNP-K functions related to processing and export of
mRNAs during ASFV infection.2. Materials and methods
2.1. Plasmids
For the yeast two-hybrid assay, plasmids pGBT9 and pACT2 (BD
Sciences) were used as sources of the GAL4 DNA-binding domain
(BD) and transcriptional activation domain (AD), respectively. To
generate pGBT9-p30, the complete p30 coding sequence was directly
ampliﬁed from ASFV genome of E70 isolate and inserted in EcoRI
and BamHI sites in pGBT9. Unrelated ASFV protein p54 was used
as negative control and cloned in pGBT9, as previously published
[18]. A cDNA library from porcine macrophage, cloned in XhoI site
in pACT2, was kindly provided by Linda Dixon [19]. p30 andby Elsevier B.V. Open access under CC BY-NC-ND license.
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involved in the interaction were generated by PCR from pGBT9-p30
and pGEX-RNP-K, respectively. The fragments generated were in-
serted in frame with AD or BD in pGBT9 or pACT2. pACT2-K, con-
taining complete hnRNP-K coding sequence fused to AD, was derived
from pGEX-RNP-K. pCMV-p30 was also derived from pGBT9-p30
and used in transfection experiments. For the glutathione S-transferase
(GST) pull-down experiments, plasmids pGEX-RNP-K (kindly pro-
vided by Dr. Levens) and pGEX-4T (GE Healthcare) were used to ex-
press GST-hnRNP-K fusion protein or GST alone in Escherichia coli.2.2. Yeast two-hybrid
pGBT9-p30 and unrelated control protein pGBT9-p54 were inde-
pendently used as baits to screen a pACT2 cDNA library from pig
macrophages in Saccharomyces cerevisiae reporter strain Y190 as pre-
viously published [18,20,21]. Yeast were sequentially transformed with
bait plasmid and pACT2 library by the lithium acetate method. After
auxotrophic and colony size selection, resulting clones were analyzed
for expression of GAL4-dependent b-galactosidase. Plasmid DNA
from those clones exhibiting b-galactosidase activity was isolated and
retransformed into yeast strain Y190 with pGBT9-p30 to eliminate
false positives. The sequence of inserts was determined by sequencing
using speciﬁc primers and compared with the data base of the NCBI
using the BLAST program. pGBT9-p30, pGBT9-p54 and pACT2-K
were individually transformed in yeast and tested for b-galactosidase
activity to exclude activation of gene reporter by itselves.
The diﬀerent mutant truncations of p30 were individually trans-
formed with pACT2-K in Y190 and resulting clones tested for expres-
sion of GAL4-dependent b-galactosidase. Similarly, diﬀerent mutant
truncations of hnRNP-K were transformed with pGBT9-p30 and
tested.2.3. GST pull-down experiments
GST-hnRNP-K and GST proteins were produced in E. coli BL21
cells, previously transformed with vector pGEX-RNP-K or pGEX-
4T. Cells were induced with 0.1 mM IPTG for 2 h at 37 C. Bacteria
were harvested and suspended in lysis buﬀer (PBS, 1% Triton X-100,
1 mM PMSF, 5 mM DTT, and anti-proteases), and sonicated on ice.
GST-hnRNP-K and GST alone were puriﬁed from cleared lysates by
mixing with glutathione-sepharose 4B beads (GE HealthCare), 5 ml
of cleared lysate/400 ll of beads, for 1 h at 4 C. After extensive wash-
ing, GST-hnRNP-K or GST beads were incubated in binding buﬀer
(50 mM HEPES, ph 7.5, 50 mM NaCl, 0.1% Nonidet P-40 with prote-
ase inhibitor mixture (Roche Molecular Biochemical)) at 4 C for 1 h
with insect cell extracts containing either p30 or p54 ASFV proteins
overexpressed in a baculovirus system [8]. Equal amounts of GST,
GST-hnRNP-K and ASFV proteins p30 and p54 were used as judged
by Coomasie Blue staining.
Alternatively, monolayers of Vero cells infected with BA71V and
lysed in 50 mMHEPES, ph 7.5, 50 mMNaCl, 0.1% Nonidet P-40 con-
taining protease inhibitor, were similarly mixed with GST-hnRNP-K
or GST beads. In all cases, after extensive washing, bound proteins
were eluted and analyzed by Western blotting with anti-p30 monoclo-
nal antibody (diluted 1:500) or anti-p54 serum (diluted 1:60).
2.4. Virus infections and immunoﬂuorescence analyses
Vero cells were grown in DMEM 5% onto cover slips, at 50–60%
conﬂuence, allowed to attached and then infected or mock infected
with 1 pfu/cell of ASFV strain BA71V. Cells were ﬁxed from 4 to 24
hpi in PBS-paraformaldehyde 3.8% and permeabilized in PBS-TX-
100 0.1% for immunoﬂuorescence analyses. In transient expression
analysis pCMV-p30 was transfected in Vero cells using Fugene6
(Roche Molecular Biochemical) according to manufacturers indica-
tions.
Anti-hnRNP-K rabbit serum and mouse monoclonal anti-p30 were
used at 1:400 and 1:100, respectively. Secondary antibodies used were
Alexa 488-conjugated goat anti-rabbit IgG (Molecular Probes) and
Rhodamine Red conjugated goat anti-mouse IgG (Molecular Probes),
both at dilution 1:300.
Incorporation of 5-ﬂuorouridine (FU; Sigma) into nascent RNA
was determined as previously [22]. Brieﬂy, transfected or BA71V in-
fected cells were pulse labelled with 5 mM FU at 37 C for 20 min.
After washing with PBS to remove residual FU, cells were ﬁxed and
permeabilized as described. Monoclonal antibody against halogenatedUTP (anti-BrU; Sigma) was used diluted 1:500 to label nascent RNA.
Speciﬁc ﬂuorescence was measured using Lasersharp Processing 3.2
program (BioRad).
Speciﬁcity of labelling and absence of signal crossover was excluded
in all cases by examination of single labelled control samples, including
labelling controls with omission of primary antibody. When indicated,
viral factories and cell nuclei were identiﬁed by direct staining of cells
with Hoechst 33342 1 lg/ml (Sigma). Finally, cells were mounted onto
slides using Fluorsave reagent (Calbiochem).
Conventional microscopy was carried out in a Leica photomicro-
scope with a digital camera and digitized images were obtained with
Qwin program (Leica).
Confocal microscopy was carried out on an MRC1024 system (Bio-
Rad) mounted on a Nikon Eclipse 300 microscope equipped with 63
and 100X objectives. Statistical analysis of colocalization was per-
formed using Lasersharp Processing 3.2 program (BioRad).
2.5. Preparation of nuclear and cytoplasmic extracts
Preconﬂuent monolayers of Vero cells were mock infected or in-
fected with ASFV strain BA71V. Cells were washed and harvested
from 0 to 24 hpi in cold PBS. Isolation of nuclear and cytoplasmic
fractions was performed as described previously [23]. Brieﬂy, cell pel-
lets were suspended in three volumes of hypotonic buﬀer and homog-
enization was carried out with a glass Dounce homogenizator. After
centrifugation at 3300 · g for 15 min, supernatant was considered as
the cytoplasmic fraction while pellets containing nuclei were suspended
in half volume of low salt buﬀer. Extraction of nuclei was performed
by adding 1 volume of high salt buﬀer for 30 min followed by centri-
fugation at 25000 · g. Resulting supernatant was considered as the nu-
clear fraction. After dialysis, 20 lg from each cytosolic sample and
13 lg from each nuclear sample were analyzed by Western blot with
speciﬁc antibodies (anti-p30, anti-hnRNP-K and anti-b-tubulin diluted
1:500, 1:10.000 and 1:500, respectively). Quality of fractionation pro-
cess was assessed by detection of b-tubulin on both nuclear and cyto-
solic samples. Bands obtained corresponding to hnRNP-K were
densitometrically quantiﬁed using an image analyzer with TINA soft-
ware package (Raytest).3. Results
3.1. Identiﬁcation of hnRNP-K as cellular interacting protein
with ASFV p30
To identify cellular proteins interacting with ASFV early
protein p30, yeast two-hybrid system was used to screen a por-
cine macrophage cDNA library. After selection from a total of
5 · 106 transformants screened, two potential positive clones
were obtained in the reporter gene assay. DNA sequence anal-
ysis showed that cDNA contained in these clones, identical in
size and composition, matched the cDNA sequence encoding
hnRNP-K. cDNA sequences from positive clones represent
nucleotides from 169 to 870 of the hnRNP-K cDNA sequence
(GeneBank accession number 241477), with 98% nucleotide
identity, corresponding to amino acid residues 13–246 of
hnRNP-K protein. To conﬁrm this result, the plasmid con-
tained in these two clones was isolated and retransformed to-
gether with pGBT9-p30 detecting b-galactosidase activity.
Conversely, clones obtained screening the library with
pGBT9-p54 never encoded a similar sequence. Moreover, no
reporter gene activity was detected in clones transformed with
pACT2-K alone, excluding activation of gene reporter by it-
self.
3.2. p30 binds directly to hnRNP-K in vitro
The interaction was further conﬁrmed by in vitro binding as-
says using a GST-hnRNP-K fusion protein bound to glutathi-
one-sepharose 4B beads. GST pull-down experiments were
carried out followed by Western blot with speciﬁc antibodies.
Fig. 2. Regions of p30 and hnRNP-K involved in the interaction. (A)
Schematic representation of the diverse p30 truncations tested for
interaction with full length hnRNP-K in the yeast two-hybrid assay.
(B) Schematic representation of the diverse hnRNP-K truncations
tested for interaction with complete p30 in the yeast two-hybrid assay.
Structure with details of the diﬀerent functional regions is shown [10].
NLS, nuclear localization signal; KH, K homology domains; KNS,
bidirectional nuclear export signal. In all cases correspondent clones
were analyzed for b-galactosidase activity indicating interaction (+) or
no interaction () with respective partner tested.
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p54 as negative control) were used to bind GST fusion protein
or GST alone. Protein p30, and not p54, was retained in the
presence of GST-hnRNP K, showing a band of appropriate
size (30 kDa) for p30 in Western blotting. This band did not
appear in the presence of GST alone, indicating speciﬁc inter-
action of p30 with hnRNP K and not with GST (Fig. 1A).
Identical results were obtained in subsequent experiments
using BA71V infected or mock-infected cells extracts instead
of baculovirus infected cell extracts in the pull-down assay
(Fig. 1B).
3.3. Mapping the interacting domains of p30 and hnRNP-K
To examine the regions of both proteins involved in this
interaction, diﬀerent truncations of p30 fused to GAL4-BD
domain and diﬀerent truncations of hnRNP-K fused to
GAL4-AD domain were tested for interaction (Fig. 2). As
p30 sequence does not contain any previously characterized
functional domain, we analyzed independently p30 amino ter-
minus, central region and carboxy terminus fragments (1–70,
1–140 and 140–204 aa residues) for hnRNP-K interaction. In
addition, diverse truncations of hnRNP-K were performed
attending to previously well characterized functional domains
[10] and tested for interaction using the yeast two-hybrid sys-
tem. The results showed that none of the three diﬀerent p30
truncations interacted with hnRNP-K (Fig. 2A). On the otherFig. 1. Interaction of viral protein p30 with hnRNP-K in the GST
fusion protein binding assay. (A) Viral protein p30, produced in the
baculovirus system, was incubated with GST or GST-hnRNP-K beads
(GST-K). Unrelated ASFV protein p54 was similarly used as negative
control. After extensive washing and elution from beads, resulting
protein complexes were electrophoresed and analyzed by WB with
monoclonal anti-p30 or anti-p54 serum (see Section 2). (B) As
described before, ASFV infected (BA71V) or mock infected (MI)
protein cell extracts were incubated with GST-hnRNP-K (GST-K)
beads and analyzed by WB with anti-p30 monoclonal antibody. In all
cases C+ indicates p30 or p54 protein extracts used as positive Western
blot controls.hand, we could determine that the hnRNP-K fragment from
amino acid residue 35–197 contained the interacting region
with p30 (Fig. 2B). This region harbours KH1 and KH2 do-
mains, identical each other, which have been previously identi-
ﬁed as functional elements responsible for RNA binding.
3.4. Partial colocalization of protein p30 and hnRNP-K in
ASFV infected cells
To ascertain the time in infection and the subcellular com-
partment at which the interaction occurs, ASFV infected cells
were examined by confocal laser scanning microscopy at diﬀer-
ent times post infection (at least 30 infected cells were analyzed
for each time point at 0, 6, 8 and 12 hpi). Newly synthesized
viral protein p30 could not be detected in the nucleus or cyto-
plasm of examined cells before 8 hpi. Since that time point, p30
and hnRNP-K were found to colocalize in discrete areas with-
in the nucleus of infected cells. Statistical analysis of colocal-
ization showed that the totality of protein p30 present in the
nucleus was detected colocalizing with hnRNP-K since 12
hpi (Fig. 3B). In contrast, most hnRNP-K was detected also
in other parts of the nucleus exhibiting no colocalization with
p30, indicating a partial colocalization of hnRNP-K with p30.
Interestingly, in the cytoplasmic region of those infected cells
hnRNP-K was barely detected and colocalization percentages
were not signiﬁcant (data not shown).
3.5. ASFV infection modiﬁes hnRNP-K distribution
Subcellular distribution of p30 and hnRNP-K were analyzed
by immunoﬂuorescence microscopy in ASFV or mock infected
cells. ASFV infection resulted in an intensiﬁcation of nuclear,
but not cytoplasmic, staining of hnRNP-K when compared to
uninfected cells. When nuclei of infected cells were examined in
detail, nuclear hnRNP-K was detected in characteristic granu-
lar structures coincident with areas completely devoid of nu-
cleic acid staining. Interestingly, these kind of hnRNP-K
accumulation was also observed in cells transiently expressing
p30 (pCMV-p30), but not in mock-infected cells, suggesting
Fig. 3. Colocalization of p30 and hnRNP-K in the nucleus of infected
cells. Cells were infected with BA71V strain and analyzed at diﬀerent
times post infection by confocal immunoﬂuorescence microscopy
acquiring 0.1 lm optical sections from the Z-axis. A representative
image of an infected cell at 8 hpi is shown (A). p30 was detected with a
monoclonal anti-p30 followed by Alexa 647-conjugated goat anti-
mouse antibody (red) and hnRNP-K with an anti-hnRNP-K speciﬁc
serum followed by Alexa 488-conjugated goat anti-rabbit antibody
(green). Discrete spots of colocalization of both proteins (orange) can
be discerned in the cell nucleus. Bar, 10 lm. (B) Quantiﬁcation of
colocalization during infection. As described above, the nuclei of 30
infected cells were analyzed each time for hnRNP-K (black bars), p30
(white bars) and colocalization (grey bars) ﬂuorescence emission. Data
are expressed as percentages and normalized to total ﬂuorescence due
to hnRNP-K exclusively within the cell nucleus.
Fig. 4. ASFV infection induces changes in subcellular distribution of
hnRNP-K. (A) Vero cells were either infected with BA71V (1 pfu/cell)
or transfected with pCMV-p30 and analyzed by immunoﬂuorescence
microscopy at 8 hpi or 24 h post transfection, respectively. ASFV
protein p30 was detected with a mouse anti-p30 monoclonal antibody
and rhodamine red conjugated corresponding secondary antibody
(red). hnRNP-K distribution in the cell nucleus was detected with a
rabbit antiserum anti-hnRNP-K and Alexa Fluor 488 conjugated
corresponding secondary antibody (green). Nuclei of cells were stained
with Hoechst 3332. Accumulation of hnRNP-K in infected cells as
spots which are coincident with the absence of nucleic acids staining
can be appreciated in BA71V infected and pCMV-p30 transfected
cells. Details of hnRNP-K accumulation are ampliﬁed from selected
areas. (B) Comparison between uninfected and 12 hpi BA71V infected
cell nuclei is shown in more detail. Arrows indicate the position of
some of these structures in detail within the nucleus of an infected cell
(bottom), but not in a non infected cell (top). VF indicates the
perinuclear viral factory, identiﬁed by Hoechst staining in an infected
cell. Bar, 16 lm.
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infection.
To conﬁrm the retention of hnRNP-K in the nucleus of in-
fected cells observed by immunoﬂuorescence, the levels of
hnRNP-K were assessed by Western blot at diﬀerent times
post infection using total, cytoplasmic and nuclear protein cell
extracts. Total levels of hnRNP-K (Fig. 5A) were determined
as infection proceeded (monitored by detection of p30) in or-
der to discard that these changes could be to due changes in
newly synthesized hnRNP-K or protein degradation. While
no changes in total hnRNP-K levels were observed, quantita-
tive analysis revealed a reduction of hnRNP-K levels in cyto-
plasm protein extracts from 12 hpi until the end of the
infectious cycle (Fig. 5B). This reduction was in agreement
with the observed increase of nuclear hnRNP-K levels, as
judged by Western blot analysis. These results are consistent
with the immunoﬂuorescence analysis and indicate nuclear
accumulation of hnRNP-K during ASFV infection.
These changes in hnRNP-K distribution might disrupt the
normal behaviour of this ribonucleoprotein which is involved
in diverse biological processes including regulation of tran-
scription and translation. To examine the transcriptional activ-
ity in ASFV infected cells we performed immunodetection of
nascent RNA after FU pulse labelling (Fig. 5C). When com-
pared with mock-infected cells, the incorporation of FU into
nascent RNA was almost completely abolished in infected cells
from 12 hpi, coincident with the time point at which hnRNP-K
redistribution was observed.4. Discussion
Infection of eukaryotic cells with large DNA viruses often
results in extensive interactions of viral gene products with
macromolecular pathways of the host cell. By using the yeast
two-hybrid system, we identiﬁed cellular hnRNP-K as an
interacting protein with ASFV early protein p30. This interac-tion was further conﬁrmed by an in vitro GST-fusion pull-
down assay, using either p30 obtained from baculovirus sys-
tem or ASFV infected cell extracts.
hnRNP-K is closely coupled to gene expression [15,24] and
signal transduction pathways [16,25]. One feature which distin-
guishes hnRNP-K from other hnRNPs is the presence of three
repeated K homology motives (KH) which are responsible for
RNA-binding [26–28]. Interestingly, the p30 interacting region
within hnRNP-K contains KH1 and KH2 motives, suggesting
that the interaction described might modify hnRNP-K func-
tions such as processing and export of the cellular mRNAs
than on signal transduction pathways.
hnRNP-K has been previously described to interact with
several proteins from diverse viruses. Core protein from Hep-
atitis C virus (HCV) and Dengue virus (DEN), are proposed to
relieve the repressive eﬀect of hnRNP-K on transcription reg-
ulation of diﬀerent human genes in vivo, disrupting the multi-
ple functions of hnRNP-K and contributing to virus
Fig. 5. Analysis of hnRNP-K levels during ASFV infection by Western blot. Vero cells were infected with 5 pfu/cell of BA71V strain and analyzed by
WB with speciﬁc antibodies at diﬀerent times after infection. (A) p30 and hnRNP-K were detected in total protein cell extracts with speciﬁc
antibodies (see Section 2). b-Tubulin was detected to ensure that same amount of total protein was loaded. (B) Levels of hnRNP-K were analyzed
independently from nuclear and cytoplasmic protein infected cell extracts. One of three representative experiments is shown including the relative
intensities of quantiﬁed hnRNP-K (rel. int.). b-Tubulin detection was included as quality control of the cellular fractionation. (C) Vero cells were
infected with BA71V (0.5 pfu/cell) and analyzed at 12 hpi for incorporation of FU into nascent RNA after FU pulse (see Section 2) to evaluate
transcriptional activity. Arrows indicate the position of infected cells identiﬁed by p30 detection with speciﬁc antibody. Note the increase of nuclear
hnRNP-K staining of infected cells when compared to the non infected cells. Bar, 30 lm.
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named ICP27) from Herpes simplex virus (HSV) suggest that
an IE63-mediated phosphorylation of hnRNP-K by casein ki-
nase 2, results in inhibition of binding to RNA, aﬀecting trans-
port of cellular mRNAs and altering the subcellular location of
hnRNP-K [13]. Nevertheless, no homology sequence in nucle-
otides or amino acids has been found when comparing these
virus proteins interacting with hnRNP-K, including p30, indi-
cating that this common interaction could occur in multiple
and diverse ways.
During ASFV infection, hnRNP-K normal function could
be aﬀected since changes related to hnRNP-K subcellular dis-
tribution are observed. First, accumulation of hnRNP-K with-
in the nucleus of ASFV infected cells was evident and
subsequently the levels of cytoplasmic hnRNP-K decreased
while nuclear levels were increased, as infection proceeded,
supporting the idea that accumulation of hnRNP-K within nu-
cleus is most likely due to relocation from cytoplasm. Changes
in hnRNP-K subcellular distribution have been reported previ-
ously in poliovirus infection where virus infection aﬀects the
normal nucleo-cytoplasmic traﬃcking of the host cell [29]. Sec-
ond, this hnRNP-K accumulation is coincident with the
appearance of granular structures in the nucleus where the
ribonucleoprotein is detected. Since no nucleic acids can be de-
tected in these areas, these structures could represent inactive
sites within the nucleus where hnRNP-K remains sequestered
as consequence of infection, as postulated for HSV1 [13]. Sim-
ilar structures have been previously reported during HCV
infection. In this case, HCV core protein and hnRNP-K also
colocalized in granules in the nucleus [12]. The presence of
p30 in nucleus colocalizing with hnRNP-K suggests an
involvement of this interaction in the appearance of these char-
acteristic structures. Moreover, the identiﬁcation of thesestructures also in cells transiently expressing p30 supports this
idea.
Interestingly, neither conventional nuclear localization nor
classical nuclear import signal have been previously found
within ASFV protein p30 sequence, since it exhibits a predom-
inantly cytoplasmic distribution. In this report we have dem-
onstrated that small amounts of p30 are also present in the
nucleus of the infected cell, so it can not be excluded that inter-
action with shuttling protein in cytoplasm could facilitate p30
traﬃc to the cell nucleus. Nevertheless, colocalization of both
proteins in the cytoplasm during infection was not detectable
by immunoﬂuorescence, probably because of the low relative
abundance of hnRNP-K in cytoplasm and its shuttling proper-
ties which diﬃcult its visualization by immunoﬂuorescence
microscopy.
In conclusion, protein p30 could have further regulatory ac-
tions associated to its speciﬁc binding to hnRNP-K protein in
the nucleus of infected cells. It is well known that viruses have
evolved diﬀerent mechanisms to alter host cell transcription
and translation to promote transcription of its own DNA
[30]. Here, we conﬁrmed that all changes observed in
hnRNP-K distribution during ASFV infection take place
simultaneously with an extraordinary reduction in 5-ﬂuouri-
dine (FU) incorporation into nascent RNA, which represents
an alteration in the cellular transcriptional activity. One way
to inhibit cellular transcription is the recruitment of host cell
RNA polymerase II. Nevertheless this is not a requirement
for ASFV, since a-amanitin does not inhibit the production
of infectious virus [31]. However, in cell systems previously
studied (macrophages and Vero cells), ASFV infection pro-
duces a general shut-oﬀ of protein synthesis that aﬀects up to
65% of the cellular proteins [2,32,33]. This inhibition of protein
synthesis is detectable very early after ASFV infection, so it
3280 B. Hernaez et al. / FEBS Letters 582 (2008) 3275–3280will be interesting to determine whether the interaction here
described is contributing to the general host cell shut-oﬀ or
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